|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.1 TWD | +0.93% |
|
+3.24% | -22.82% |
TAIPEI, July 19 (Reuters) - Taiwan's government on Monday approved the production of Medigen Vaccine Biologics Corp's COVID-19 vaccine candidate.
The health ministry said in clinical trials in Taiwan the antibodies created by Medigen's vaccine candidate have been proven to be "no worse than" those created by AstraZeneca PLC vaccines, and that there were no major safety concerns. (Reporting by Ben Blanchard and Yimou Lee; Editing by Christopher Cushing)
| 1st Jan change | Capi. | |
|---|---|---|
| -22.82% | 548M | |
| -2.61% | 89.08B | |
| +3.55% | 40.9B | |
| -14.40% | 32.25B | |
| +55.89% | 25.14B | |
| -15.96% | 15.39B | |
| -15.50% | 11.91B | |
| -41.29% | 11.89B | |
| -11.75% | 11.64B | |
| +7.87% | 9.03B |
MEDIGEN VACCINE BIOLOGICS CORPORATION 